# Implantation or Injectable Dosage Form New Animal Drugs; Danofloxacin
> **Food and Drug Administration** · Final rule. · Published 2012-01-27 · Effective 2012-01-27 · 77 FR 4226
## Document
- **Document number:** 2012-1743
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 77 FR 4226
- **CFR reference:** 21 CFR 522
- **Publication date:** 2012-01-27
- **Effective date:** 2012-01-27
- **HHS docket:** Docket No. FDA-2011-N-0003
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Pfizer, Inc. The supplemental NADA provides for an additional dosage regimen for use of danofloxacin mesylate injectable solution for the treatment of bovine respiratory disease in beef cattle.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2012/01/27/2012-1743/implantation-or-injectable-dosage-form-new-animal-drugs-danofloxacin)
---
*AI Analytics · CC0 1.0*